| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Respiration, Artificial | 37 | 2021 | 22116 | 1.92 | Why? |
| Positive-Pressure Respiration | 13 | 2021 | 1160 | 1.68 | Why? |
| Ventilator-Induced Lung Injury | 7 | 2019 | 260 | 1.55 | Why? |
| Developing Countries | 18 | 2021 | 4283 | 1.38 | Why? |
| Tidal Volume | 10 | 2021 | 565 | 1.34 | Why? |
| Sepsis | 17 | 2019 | 3517 | 1.28 | Why? |
| Intensive Care Units | 37 | 2021 | 29594 | 1.02 | Why? |
| Critical Care | 15 | 2020 | 14081 | 0.92 | Why? |
| Pneumonia, Ventilator-Associated | 5 | 2017 | 861 | 0.82 | Why? |
| Pulmonary Atelectasis | 1 | 2020 | 80 | 0.78 | Why? |
| Ventilators, Mechanical | 6 | 2021 | 2193 | 0.77 | Why? |
| Tracheostomy | 6 | 2021 | 1963 | 0.76 | Why? |
| Health Resources | 6 | 2020 | 2592 | 0.72 | Why? |
| Postoperative Complications | 10 | 2019 | 5861 | 0.71 | Why? |
| Critical Care Outcomes | 1 | 2018 | 138 | 0.69 | Why? |
| Protein C | 3 | 2017 | 141 | 0.69 | Why? |
| Pulmonary Medicine | 3 | 2020 | 706 | 0.68 | Why? |
| Respiratory System Agents | 1 | 2018 | 63 | 0.66 | Why? |
| Ultrasonography | 5 | 2021 | 4409 | 0.65 | Why? |
| Practice Guidelines as Topic | 13 | 2021 | 15421 | 0.60 | Why? |
| Respiratory Insufficiency | 7 | 2021 | 7301 | 0.59 | Why? |
| Ventilator Weaning | 4 | 2018 | 536 | 0.55 | Why? |
| Lung | 18 | 2021 | 31049 | 0.52 | Why? |
| Critical Illness | 16 | 2021 | 17281 | 0.51 | Why? |
| Burns | 1 | 2019 | 466 | 0.48 | Why? |
| Continuous Positive Airway Pressure | 2 | 2021 | 1187 | 0.46 | Why? |
| Health Services Research | 1 | 2018 | 756 | 0.45 | Why? |
| Respiratory Mechanics | 5 | 2021 | 585 | 0.44 | Why? |
| Respiratory Therapy | 1 | 2018 | 918 | 0.42 | Why? |
| Oxygen | 3 | 2021 | 3715 | 0.42 | Why? |
| Anesthesia | 2 | 2018 | 1236 | 0.42 | Why? |
| Blood Glucose | 4 | 2017 | 3642 | 0.41 | Why? |
| Netherlands | 12 | 2021 | 3533 | 0.41 | Why? |
| Home Care Services | 1 | 2021 | 1351 | 0.40 | Why? |
| Glycemic Index | 1 | 2010 | 115 | 0.39 | Why? |
| Quality of Health Care | 2 | 2018 | 1948 | 0.39 | Why? |
| Quality Improvement | 3 | 2018 | 2435 | 0.39 | Why? |
| Gastrointestinal Tract | 1 | 2017 | 1113 | 0.37 | Why? |
| Oropharynx | 1 | 2017 | 1581 | 0.36 | Why? |
| Health Care Costs | 1 | 2017 | 1007 | 0.36 | Why? |
| Decontamination | 1 | 2017 | 1196 | 0.34 | Why? |
| Abdomen | 4 | 2018 | 424 | 0.34 | Why? |
| Humans | 116 | 2021 | 930598 | 0.34 | Why? |
| Hemofiltration | 1 | 2009 | 155 | 0.33 | Why? |
| Hypothermia, Induced | 2 | 2019 | 176 | 0.32 | Why? |
| Hypoventilation | 1 | 2005 | 17 | 0.30 | Why? |
| Blood Coagulation | 3 | 2021 | 2768 | 0.30 | Why? |
| Hemodynamics | 3 | 2018 | 1562 | 0.30 | Why? |
| Thailand | 2 | 2020 | 1155 | 0.30 | Why? |
| Guideline Adherence | 1 | 2018 | 2309 | 0.30 | Why? |
| Breath Tests | 3 | 2017 | 338 | 0.29 | Why? |
| Pneumonia, Pneumococcal | 2 | 2018 | 251 | 0.29 | Why? |
| Postoperative Care | 1 | 2010 | 755 | 0.28 | Why? |
| Lung Diseases | 4 | 2019 | 2361 | 0.28 | Why? |
| Muscle Weakness | 2 | 2018 | 406 | 0.27 | Why? |
| Coronary Artery Bypass | 1 | 2010 | 629 | 0.27 | Why? |
| Evidence-Based Medicine | 3 | 2020 | 3228 | 0.26 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.26 | Why? |
| Shock, Septic | 3 | 2017 | 1313 | 0.25 | Why? |
| Anesthesia, General | 2 | 2018 | 470 | 0.25 | Why? |
| Triage | 2 | 2021 | 7151 | 0.25 | Why? |
| Blood Glucose Self-Monitoring | 1 | 2008 | 791 | 0.24 | Why? |
| Rewarming | 2 | 2019 | 11 | 0.24 | Why? |
| Disease Management | 4 | 2021 | 6841 | 0.24 | Why? |
| Tuberculosis | 1 | 2018 | 2895 | 0.24 | Why? |
| Monitoring, Physiologic | 3 | 2018 | 1956 | 0.24 | Why? |
| Probiotics | 1 | 2010 | 694 | 0.24 | Why? |
| Inflammation Mediators | 3 | 2018 | 2654 | 0.23 | Why? |
| Respiratory Dead Space | 1 | 2021 | 36 | 0.23 | Why? |
| Patient Admission | 1 | 2018 | 5250 | 0.23 | Why? |
| Cross Infection | 3 | 2019 | 8675 | 0.22 | Why? |
| Betacoronavirus | 10 | 2020 | 204454 | 0.22 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.22 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.21 | Why? |
| Drug Utilization | 1 | 2006 | 619 | 0.21 | Why? |
| Prone Position | 3 | 2021 | 1861 | 0.21 | Why? |
| Volatile Organic Compounds | 3 | 2017 | 187 | 0.21 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.20 | Why? |
| Smoke Inhalation Injury | 1 | 2019 | 22 | 0.20 | Why? |
| Prospective Studies | 17 | 2019 | 43301 | 0.20 | Why? |
| Receptor for Advanced Glycation End Products | 2 | 2018 | 100 | 0.20 | Why? |
| Serum Bactericidal Test | 1 | 2018 | 7 | 0.20 | Why? |
| Minimally Invasive Surgical Procedures | 1 | 2005 | 663 | 0.20 | Why? |
| Postoperative Period | 2 | 2018 | 651 | 0.19 | Why? |
| Recombinant Proteins | 2 | 2009 | 3786 | 0.19 | Why? |
| Hypothermia | 1 | 2019 | 59 | 0.19 | Why? |
| HMGB1 Protein | 1 | 2021 | 223 | 0.19 | Why? |
| Delphi Technique | 2 | 2021 | 1257 | 0.19 | Why? |
| Receptor, PAR-2 | 1 | 2018 | 27 | 0.18 | Why? |
| Imatinib Mesylate | 1 | 2021 | 327 | 0.18 | Why? |
| Delivery of Health Care | 3 | 2021 | 15909 | 0.18 | Why? |
| Intraabdominal Infections | 1 | 2019 | 90 | 0.18 | Why? |
| Perioperative Care | 2 | 2020 | 1329 | 0.18 | Why? |
| Barotrauma | 1 | 2019 | 97 | 0.18 | Why? |
| Safety | 2 | 2020 | 1583 | 0.17 | Why? |
| Randomized Controlled Trials as Topic | 4 | 2018 | 10649 | 0.17 | Why? |
| Male | 46 | 2021 | 367725 | 0.17 | Why? |
| Electronic Nose | 1 | 2017 | 36 | 0.17 | Why? |
| Albuterol | 1 | 2018 | 105 | 0.17 | Why? |
| Protein Kinase Inhibitors | 2 | 2021 | 1585 | 0.17 | Why? |
| Neuromuscular Blocking Agents | 1 | 2018 | 121 | 0.17 | Why? |
| Hypoglycemia | 3 | 2017 | 406 | 0.17 | Why? |
| Fibrinolytic Agents | 1 | 2009 | 1702 | 0.17 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.17 | Why? |
| Berlin | 1 | 2017 | 283 | 0.17 | Why? |
| Consensus | 3 | 2021 | 6345 | 0.17 | Why? |
| Rwanda | 1 | 2017 | 270 | 0.17 | Why? |
| Middle Aged | 37 | 2021 | 270681 | 0.17 | Why? |
| Female | 44 | 2021 | 380317 | 0.17 | Why? |
| Anesthetics | 1 | 2020 | 196 | 0.16 | Why? |
| Bronchoscopy | 1 | 2005 | 991 | 0.16 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.16 | Why? |
| Fasciitis, Necrotizing | 1 | 2017 | 56 | 0.16 | Why? |
| Point-of-Care Systems | 2 | 2021 | 2955 | 0.16 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.16 | Why? |
| Phenotype | 2 | 2018 | 4037 | 0.16 | Why? |
| Exhalation | 2 | 2017 | 441 | 0.16 | Why? |
| Herpesviridae | 1 | 2017 | 100 | 0.16 | Why? |
| Cellulitis | 1 | 2017 | 119 | 0.15 | Why? |
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 230 | 0.15 | Why? |
| Streptococcus pneumoniae | 2 | 2018 | 827 | 0.15 | Why? |
| Intubation, Intratracheal | 2 | 2017 | 3962 | 0.15 | Why? |
| Biomarkers | 14 | 2021 | 23361 | 0.15 | Why? |
| Intraoperative Care | 1 | 2017 | 238 | 0.15 | Why? |
| Walking | 1 | 2020 | 442 | 0.15 | Why? |
| False Positive Reactions | 1 | 2021 | 1338 | 0.15 | Why? |
| Laparotomy | 1 | 2017 | 241 | 0.15 | Why? |
| Lipopolysaccharides | 2 | 2018 | 848 | 0.15 | Why? |
| Acetylcysteine | 1 | 2018 | 255 | 0.15 | Why? |
| Herpesviridae Infections | 1 | 2017 | 172 | 0.14 | Why? |
| Rehabilitation | 1 | 2021 | 386 | 0.14 | Why? |
| Toll-Like Receptors | 1 | 2018 | 365 | 0.14 | Why? |
| Cohort Studies | 10 | 2021 | 36005 | 0.14 | Why? |
| Treatment Outcome | 10 | 2021 | 51732 | 0.14 | Why? |
| Goals | 1 | 2018 | 335 | 0.14 | Why? |
| Intubation | 1 | 2017 | 437 | 0.14 | Why? |
| Body Weight | 2 | 2018 | 1074 | 0.14 | Why? |
| Drug Resistance | 1 | 2017 | 395 | 0.14 | Why? |
| Aged | 29 | 2021 | 215776 | 0.14 | Why? |
| Interleukin-8 | 2 | 2017 | 964 | 0.13 | Why? |
| Respiratory Function Tests | 4 | 2021 | 1755 | 0.13 | Why? |
| Spirometry | 1 | 2017 | 524 | 0.13 | Why? |
| Nebulizers and Vaporizers | 1 | 2018 | 497 | 0.13 | Why? |
| Metabolomics | 2 | 2017 | 921 | 0.13 | Why? |
| False Negative Reactions | 1 | 2021 | 1785 | 0.13 | Why? |
| Patient Acuity | 1 | 2021 | 1755 | 0.13 | Why? |
| Europe | 5 | 2020 | 12702 | 0.13 | Why? |
| Platelet Activation | 1 | 2018 | 660 | 0.13 | Why? |
| Pandemics | 10 | 2020 | 389249 | 0.13 | Why? |
| Calcium Channel Blockers | 1 | 2017 | 367 | 0.13 | Why? |
| Diffusion of Innovation | 1 | 2018 | 440 | 0.13 | Why? |
| Expert Testimony | 1 | 2017 | 658 | 0.13 | Why? |
| Length of Stay | 5 | 2018 | 11042 | 0.13 | Why? |
| Shock | 1 | 2020 | 1868 | 0.12 | Why? |
| Advisory Committees | 1 | 2020 | 1418 | 0.12 | Why? |
| Global Burden of Disease | 1 | 2017 | 531 | 0.12 | Why? |
| Patient Care Planning | 1 | 2018 | 582 | 0.12 | Why? |
| Inservice Training | 1 | 2017 | 477 | 0.12 | Why? |
| Cyclin-Dependent Kinases | 1 | 2012 | 124 | 0.12 | Why? |
| Internationality | 3 | 2020 | 3297 | 0.12 | Why? |
| Body Temperature | 1 | 2018 | 875 | 0.12 | Why? |
| Tomography, X-Ray Computed | 6 | 2021 | 25144 | 0.12 | Why? |
| Demography | 1 | 2019 | 1660 | 0.12 | Why? |
| Interleukin-6 | 3 | 2021 | 7522 | 0.12 | Why? |
| Patient Selection | 2 | 2018 | 4560 | 0.11 | Why? |
| Erythrocyte Aging | 1 | 2010 | 13 | 0.11 | Why? |
| Acute Lung Injury | 2 | 2010 | 904 | 0.11 | Why? |
| Immunomodulation | 1 | 2020 | 1472 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Medical Staff, Hospital | 1 | 2020 | 1258 | 0.10 | Why? |
| Prebiotics | 1 | 2010 | 53 | 0.10 | Why? |
| Hospital Mortality | 4 | 2018 | 22087 | 0.10 | Why? |
| Robotic Surgical Procedures | 1 | 2018 | 787 | 0.10 | Why? |
| Airway Management | 1 | 2020 | 1298 | 0.10 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.10 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.10 | Why? |
| Viremia | 1 | 2017 | 1020 | 0.10 | Why? |
| International Cooperation | 2 | 2020 | 3436 | 0.10 | Why? |
| Patient Care | 1 | 2020 | 1664 | 0.10 | Why? |
| Infection Control | 5 | 2021 | 23131 | 0.10 | Why? |
| Anticoagulants | 2 | 2021 | 9563 | 0.10 | Why? |
| Research Design | 2 | 2017 | 5830 | 0.10 | Why? |
| Hypoxia | 2 | 2021 | 3626 | 0.09 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.09 | Why? |
| Clinical Protocols | 2 | 2020 | 2734 | 0.09 | Why? |
| Pneumonia | 4 | 2019 | 5652 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.09 | Why? |
| Adult | 17 | 2021 | 244371 | 0.09 | Why? |
| Disseminated Intravascular Coagulation | 1 | 2017 | 994 | 0.09 | Why? |
| Bacterial Load | 2 | 2018 | 179 | 0.09 | Why? |
| Out-of-Hospital Cardiac Arrest | 1 | 2018 | 1047 | 0.09 | Why? |
| Preoperative Period | 2 | 2019 | 271 | 0.09 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2021 | 9706 | 0.09 | Why? |
| Respiratory System | 2 | 2018 | 3213 | 0.08 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.08 | Why? |
| Multicenter Studies as Topic | 3 | 2018 | 2437 | 0.08 | Why? |
| Purines | 1 | 2012 | 816 | 0.08 | Why? |
| Blood Platelets | 1 | 2018 | 1704 | 0.08 | Why? |
| Microbiota | 1 | 2017 | 1240 | 0.08 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.08 | Why? |
| Erythrocyte Transfusion | 1 | 2010 | 386 | 0.08 | Why? |
| Observational Studies as Topic | 3 | 2018 | 1887 | 0.08 | Why? |
| Contraindications | 1 | 2006 | 96 | 0.08 | Why? |
| Time Factors | 5 | 2021 | 31397 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.07 | Why? |
| Genomics | 1 | 2017 | 3118 | 0.07 | Why? |
| APACHE | 2 | 2018 | 682 | 0.07 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.07 | Why? |
| Sex Factors | 2 | 2019 | 11014 | 0.07 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.07 | Why? |
| Patient Discharge | 1 | 2021 | 5696 | 0.07 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.07 | Why? |
| Double-Blind Method | 3 | 2021 | 5988 | 0.07 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.07 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.07 | Why? |
| Clinical Laboratory Techniques | 2 | 2021 | 23402 | 0.06 | Why? |
| Surgical Procedures, Operative | 1 | 2019 | 2662 | 0.06 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.06 | Why? |
| ROC Curve | 3 | 2021 | 6024 | 0.06 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
| Radiography, Thoracic | 1 | 2019 | 5486 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.06 | Why? |
| Immunization, Passive | 1 | 2018 | 10067 | 0.06 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.06 | Why? |
| Models, Biological | 1 | 2019 | 4907 | 0.06 | Why? |
| Personal Protective Equipment | 3 | 2021 | 15978 | 0.06 | Why? |
| Blood Gas Analysis | 1 | 2005 | 893 | 0.06 | Why? |
| Risk Factors | 7 | 2021 | 71621 | 0.06 | Why? |
| Anti-Bacterial Agents | 3 | 2019 | 10083 | 0.05 | Why? |
| Urinary Tract Infections | 1 | 2007 | 534 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 2 | 2018 | 6653 | 0.05 | Why? |
| Mass Screening | 1 | 2021 | 8005 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2021 | 5762 | 0.05 | Why? |
| Apnea | 1 | 2020 | 58 | 0.05 | Why? |
| Communication | 1 | 2018 | 5206 | 0.05 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.05 | Why? |
| Biomedical Research | 2 | 2017 | 5270 | 0.05 | Why? |
| Capillary Permeability | 1 | 2021 | 277 | 0.05 | Why? |
| Healthcare Disparities | 1 | 2017 | 3893 | 0.05 | Why? |
| Hyperglycemia | 1 | 2010 | 1363 | 0.05 | Why? |
| Urinalysis | 1 | 2021 | 218 | 0.05 | Why? |
| Intraoperative Period | 1 | 2018 | 97 | 0.05 | Why? |
| Helminth Proteins | 1 | 2018 | 32 | 0.05 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2018 | 2309 | 0.05 | Why? |
| Placebos | 1 | 2021 | 629 | 0.04 | Why? |
| Work of Breathing | 1 | 2018 | 86 | 0.04 | Why? |
| Chemokine CX3CL1 | 1 | 2017 | 26 | 0.04 | Why? |
| Inflammation | 2 | 2018 | 13255 | 0.04 | Why? |
| Membrane Glycoproteins | 1 | 2007 | 2273 | 0.04 | Why? |
| Heparin | 2 | 2021 | 2600 | 0.04 | Why? |
| Specific Pathogen-Free Organisms | 1 | 2018 | 358 | 0.04 | Why? |
| Drug Prescriptions | 1 | 2006 | 1062 | 0.04 | Why? |
| Electric Impedance | 1 | 2019 | 283 | 0.04 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.04 | Why? |
| Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.04 | Why? |
| Calibration | 1 | 2018 | 307 | 0.04 | Why? |
| Reproducibility of Results | 3 | 2018 | 11304 | 0.04 | Why? |
| Gene Expression Regulation | 2 | 2021 | 4020 | 0.04 | Why? |
| Operative Time | 1 | 2018 | 450 | 0.04 | Why? |
| Gas Chromatography-Mass Spectrometry | 1 | 2017 | 187 | 0.04 | Why? |
| Acute Disease | 2 | 2021 | 6029 | 0.04 | Why? |
| Rats | 2 | 2017 | 2764 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Genetic Markers | 1 | 2017 | 318 | 0.04 | Why? |
| Receptors, Immunologic | 2 | 2012 | 555 | 0.04 | Why? |
| Wakefulness | 1 | 2021 | 598 | 0.04 | Why? |
| Sample Size | 1 | 2018 | 518 | 0.04 | Why? |
| Rats, Wistar | 1 | 2017 | 621 | 0.04 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
| Tertiary Care Centers | 3 | 2017 | 8248 | 0.04 | Why? |
| Peritoneal Dialysis | 1 | 2021 | 498 | 0.04 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.04 | Why? |
| Hospitals, University | 2 | 2018 | 4173 | 0.03 | Why? |
| Muscle Strength | 1 | 2017 | 317 | 0.03 | Why? |
| Pulmonary Gas Exchange | 1 | 2017 | 414 | 0.03 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.03 | Why? |
| Remission Induction | 1 | 2018 | 950 | 0.03 | Why? |
| Positron-Emission Tomography | 1 | 2019 | 802 | 0.03 | Why? |
| Infant | 1 | 2017 | 30274 | 0.03 | Why? |
| Reference Standards | 1 | 2018 | 1163 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2018 | 657 | 0.03 | Why? |
| Developed Countries | 1 | 2017 | 500 | 0.03 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2018 | 572 | 0.03 | Why? |
| RNA, Ribosomal, 16S | 1 | 2017 | 793 | 0.03 | Why? |
| Antithrombins | 1 | 2017 | 353 | 0.03 | Why? |
| Influenza, Human | 1 | 2018 | 10779 | 0.03 | Why? |
| Pleural Effusion | 1 | 2019 | 680 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.03 | Why? |
| Ventilation | 1 | 2020 | 1145 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.03 | Why? |
| Risk Assessment | 3 | 2019 | 25439 | 0.03 | Why? |
| Fluid Therapy | 1 | 2017 | 628 | 0.03 | Why? |
| Nepal | 1 | 2017 | 1004 | 0.03 | Why? |
| Mice | 3 | 2018 | 21357 | 0.03 | Why? |
| Animals | 6 | 2018 | 78931 | 0.03 | Why? |
| Lipocalins | 1 | 2011 | 19 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.03 | Why? |
| Trachea | 1 | 2017 | 894 | 0.03 | Why? |
| Disease Models, Animal | 3 | 2018 | 10998 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2018 | 1647 | 0.03 | Why? |
| Income | 1 | 2021 | 1564 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2017 | 1475 | 0.03 | Why? |
| Bangladesh | 1 | 2017 | 1620 | 0.03 | Why? |
| Asia | 1 | 2018 | 2399 | 0.03 | Why? |
| Pneumothorax | 1 | 2019 | 758 | 0.03 | Why? |
| Dysbiosis | 1 | 2017 | 685 | 0.03 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.03 | Why? |
| Signal Transduction | 2 | 2018 | 7207 | 0.03 | Why? |
| Cystatin C | 1 | 2011 | 125 | 0.03 | Why? |
| Acute-Phase Proteins | 1 | 2011 | 177 | 0.03 | Why? |
| Lipocalin-2 | 1 | 2011 | 156 | 0.03 | Why? |
| Hand Hygiene | 1 | 2020 | 1493 | 0.03 | Why? |
| Interleukin-10 | 1 | 2017 | 1409 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2017 | 1648 | 0.03 | Why? |
| Cluster Analysis | 1 | 2018 | 3001 | 0.03 | Why? |
| Lymphocyte Subsets | 1 | 2017 | 987 | 0.03 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.02 | Why? |
| Pneumonia, Bacterial | 1 | 2017 | 843 | 0.02 | Why? |
| Proto-Oncogene Proteins | 1 | 2011 | 340 | 0.02 | Why? |
| Sodium Chloride | 1 | 2010 | 203 | 0.02 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.02 | Why? |
| Delayed Diagnosis | 1 | 2018 | 1529 | 0.02 | Why? |
| United States | 3 | 2020 | 46150 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.02 | Why? |
| Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2007 | 40 | 0.02 | Why? |
| Rats, Sprague-Dawley | 1 | 2010 | 987 | 0.02 | Why? |
| Elective Surgical Procedures | 1 | 2005 | 5338 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Endothelial Cells | 1 | 2017 | 2048 | 0.02 | Why? |
| Lung Injury | 1 | 2016 | 919 | 0.02 | Why? |
| Age Factors | 2 | 2018 | 21039 | 0.02 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2010 | 669 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Cytokines | 2 | 2018 | 15010 | 0.02 | Why? |
| Poverty | 1 | 2017 | 2302 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2018 | 51949 | 0.02 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.02 | Why? |
| General Surgery | 1 | 2017 | 1472 | 0.02 | Why? |
| Health Status | 1 | 2018 | 3259 | 0.02 | Why? |
| Australia | 1 | 2018 | 6306 | 0.02 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| Mass Spectrometry | 1 | 2010 | 1165 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2017 | 2165 | 0.02 | Why? |
| HEK293 Cells | 1 | 2018 | 8394 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Patient Care Team | 1 | 2018 | 3556 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.02 | Why? |
| Machine Learning | 1 | 2019 | 4395 | 0.02 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.02 | Why? |
| Apoptosis | 1 | 2012 | 2335 | 0.01 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3832 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.01 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Cells, Cultured | 1 | 2012 | 5835 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2019 | 53120 | 0.01 | Why? |
| Brain | 1 | 2017 | 5133 | 0.01 | Why? |
| Attitude of Health Personnel | 1 | 2017 | 4741 | 0.01 | Why? |
| India | 1 | 2017 | 11875 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Heart Failure | 1 | 2019 | 6638 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.01 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.01 | Why? |
| Registries | 1 | 2017 | 12327 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2021 | 14232 | 0.01 | Why? |
| Neutrophils | 1 | 2012 | 5476 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2017 | 8207 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.01 | Why? |
| Prevalence | 1 | 2016 | 25773 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |